Follow our progress as we transform solid tumor treatment.
Press Release | December 12, 2023
cTRL Therapeutics Appoints Ruben Rodriguez, Ph.D., as Head of Research
Press Release | November 1, 2023
cTRL Therapeutics Appoints Derrell D. Porter, M.D., as Chief Executive Officer
Press Release | April 10, 2023
cTRL Therapeutics Launches with $10M Seed Financing to Advance Next-Generation Cell Therapy Platform for the Treatment of Solid Tumors
In The News | April 10, 2023
A new cell therapy biotech emerges to find solid tumor-killing immune cells in patients' blood
Press Release | October 10, 2024
cTRL Therapeutics Expands in Toronto, Ontario, with Key Investment from FACIT
Press Release | October 18, 2024
cTRL Therapeutics to Present Novel Data on cTRL Platform at SITC Annual Meeting 2024
Press Release | November 7, 2024
cTRL Therapeutics to Present Promising New Data on Circulating Tumor-Reactive Lymphocytes (cTRLs) at SITC Annual Meeting 2024